Hupe, M. C., Philippi, C., & Duensing, S. (2018). Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis. Frontiers in oncology, 8, . https://doi.org/10.3389/fonc.2018.00623
Chicago-Zitierstil (17. Ausg.)Hupe, Marie Christine, Christian Philippi, und Stefan Duensing. "Expression of Prostate-specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis." Frontiers in Oncology 8 (2018). https://doi.org/10.3389/fonc.2018.00623.
MLA-Zitierstil (9. Ausg.)Hupe, Marie Christine, et al. "Expression of Prostate-specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis." Frontiers in Oncology, vol. 8, 2018, https://doi.org/10.3389/fonc.2018.00623.